Susquehanna International Group, LLP Mesoblast LTD Put Options Transaction History

Susquehanna International Group, LLP

  • $527 Billion
  • Q2 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$1.0 - $1.39 $136,300 - $189,457
136,300 Added 108.52%
261,900 $288,000
Q3 2023

Nov 14, 2023
BUY
$1.22 - $4.83 $153,232 - $606,648
125,600 New
125,600 $154,000
Q4 2022

Feb 14, 2023
SELL
$2.73 - $3.7 $150,423 - $203,870
-55,100 Reduced 38.24%
89,000 $258,000
Q3 2022

Nov 14, 2022
SELL
$0.48 - $3.48 $11,808 - $85,608
-24,600 Reduced 14.58%
144,100 $367,000

Others Institutions Holding MESO

# of Institutions
3
Shares Held
151K
Call Options Held
0
Put Options Held
0
View Full List

About MESOBLAST LTD

MESO Quotes by TradingView
  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $1.2B
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email